Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 19c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Kushner: conversations between U.S. and different areas of Iran govt are more robust than it has every been
• ExxonMobil awards $1.1 billion in contracts for Mozambique LNG
• Trump on North Korea's Kim Jong Un: he has responded to me